InspireMD (NYSE:NSPR) this week announced it appointed Andrea Tommasoli as chief operating officer.
Tommasoli was previously the company’s senior VP of global sales and marketing since November 2020. Prior to joining InspireMD, Tommasoli was most recently the senior sales director of indirect markets at Integra Lifesciences.
“Andrea has been instrumental in expanding the footprint of CGuard EPS across our approved markets in the EU and, as we advance toward potential U.S. approval with our ongoing U.S. Investigational Device Exemption (IDE) clinical trial, and as our business requirements shift toward operational capacity to support our commercial growth, we believe his background and skill set make him an ideal candidate to assume the role of chief operating officer of the company at this important time,” CEO Marvin Slosman said in a news release. “On behalf of the entire InspireMD team, I would like to congratulate Andrea on this promotion and look forward to his continued contributions.”
Tommasoli has also held numerous leadership roles in the medtech industry. He was previously the director of St. Jude Medical’s neuromodulation division in France.
“I joined InspireMD because of the tremendous potential of the CGuard EPS stent platform in changing the standard of care for Carotid revascularization through our proprietary MicroNet technology,” Tommasoli said. “As the needs of the business grow beyond European commercialization, I am pleased to be able to play a more significant leadership role with broader responsibilities to drive scalability and operational efficiency to meet our anticipated growth needs. I am highly confident in the company’s ability to meet these ever-expanding drivers of growth and look forward to serving in this important role.”
